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ABSTRACT
There are an estimated 6.1 million Americans currently diagnosed with Alzheimer’s disease
(AD) with this number expected to rapidly grow over the next 30 years. Delusions are reported in
roughly one-third of individuals with AD (Ropacki & Jeste, 2005). Delusions in AD are related to
worse outcomes; greater caregiver burden, functional decline, and overall, worse general health
(Murray et al., 2014). Current treatment options are limited given the health risks related to
antipsychotics in the elderly (Creese et al., 2018). In the current study, we examined the
relationship between APOE ε4 allele status, CA1 subfield volumes, and the presence of delusions
in a combined Alzheimer’s disease dataset (OASIS and ADNI) in a two-prong fashion. First, we
examined the moderating effect of APOE ε4 allele on the relationship of the CA1 volumes and
delusions and MMSE scores, separately. Second, we examined the specificity of that effect by
comparing CA1 volumes to other hippocampal subfields in a repeated measure model. Individuals
with delusions had smaller right CA1 volumes than individuals without delusions but this was
unrelated to APOE ε4 alleles. There was no significant moderation of the APOE ε4 alleles on the
relationship between the CA1 subfields and the presence of delusions. There was a significant
relationship between left CA1 volumes, APOE ε4 allele presence, and MMSE scores. These
findings do not completely dissuade a subcortical relationship with delusions as no other notable
differences between individuals with delusions and individuals without delusions were found in
demographic information, genetic information, or cognitive measures. Future research is needed
to examine the relationship between the hippocampus and delusions in other imaging capacities
(e.g., longitudinal studies, functional connectivity) and along more detailed presentations of
delusions.
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INTRODUCTION AND LITERATURE REVIEW

1.1 Purpose of the Study
Alzheimer’s disease (AD) is the fifth leading cause of death in individuals over 65 years old
and affects roughly 6.1 million Americans (Kochanek et al., 2020; Matthews et al., 2019). AD is
a progressive disease characterized by increasing cognitive impairment with comorbid
presentations of motor deficits, depression, irritability, hallucinations, and delusions (Murray et
al., 2014). Psychosis in Alzheimer’s disease (AD) is estimated between 10 and 73% with an
average prevalence of approximately 50% (Fischer & Sweet, 2016; Murray et al., 2014; Tzeng et
al., 2018). Delusions are reported in roughly one-third of individuals with AD (Ropacki & Jeste,
2005) and in roughly half of individuals with dementia with Lewy bodies (DLB) (Tzeng et al.,
2018). Delusions in AD are related to worse outcomes: greater caregiver burden, higher rates of
institutionalization, functional decline, and overall, worse general health (Murray et al., 2014).
Current treatment options typically involve antipsychotics; however, antipsychotics are known to
increase risk for falls, cardiovascular issues, blood clots, stroke, and overall sedation in elderly
individuals, and therefore need to be administered with caution. Understanding the genetic and
neural underpinnings of delusions in AD can help inform what genetic factors are interacting with
neurodegeneration that relate to a vulnerability to the development of delusions and therefore,
point towards new treatment options such as transcranial magnetic stimulation (TMS) that can
target (directly and indirectly) nerve cells in specific regions to moderate symptoms associated
with dysfunction in those regions.
One of the strongest genetic risk factors for AD is the apolipoprotein E (APOE) (ε4) allele.
The APOE ε4 allele accounts for approximately 50-60% of the genetic variation in AD (Cacabelos
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et al., 2003; Liu et al., 2013; Stocker et al., 2018). Possession of one APOE ε4 increases risk
between 2- and 4-fold for developing AD, whereas possession of two APOE ε4 alleles increases
risk 8- to 12-fold (Belloy et al., 2019; Liu et al., 2013). Although APOE ε4 is a known major
genetic risk factor for AD, mere possession is not sufficient or direct enough to cause AD. The
exact mechanisms involved in this pathogenesis and how it relates to AD are still not fully
understood. In addition to its known risk for AD, the APOE ε4 allele has been associated with
other clinical phenotypes, more severe positive symptoms (hallucinations and delusions) in people
with schizophrenia, and the psychosis phenotypes of AD (Burke et al., 2016; Christie et al., 2012;
Digney et al., 2005; Zubenko et al., 1996). The APOE ε4 allele appears to relate to, or at least
influence, multiple phenotypes of psychiatric or neurogenerative presentations. However, how the
APOE ε4 allele relates to specific phenotype of AD and delusions is still not fully understood.
Therefore, examination of the overlap of gray matter atrophy in the hippocampus found in AD
(Möller et al., 2013; Padurariu et al., 2012) and psychosis (specifically delusions) (Guimond et al.,
2021), and the APOE ε4 genotype (Taylor et al., 2014a) is an important next step in understanding
the potential association between this genotype and the unique clinical phenotype of delusions in
AD.
The CA1 subfield of the hippocampus has been implicated in novelty detection,
autobiographical memories, and autonoetic consciousness (Bartsch et al., 2011a). The CA1
subsfield has previously been implicated in individuals presenting with psychosis, not specific to
any one disorder. Pyramidal cell death in the CA1 was originally hypothesized as the cause of
paranoid delusions (Krieckhaus et al., 1992). In addition, shape deformity of the CA1 has been
correlated with delusion and hallucination severity in schizophrenia (Zierhut et al., 2013). In AD,
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carriers of the APOE ε4 allele exhibit greater hippocampal volume loss, specifically in the CA1
region (Kerchner et al., 2014; Padurariu et al., 2012).
The overlap in gray matter alterations identified in the hippocampus, specifically in the
CA1 region, in AD, delusions, and APOE ε4 status indicate potential support for an association
between the APOE ε4 allele and delusions. The question remains if CA1 atrophy is associated
specifically with delusions in AD, and if so, how does the presence of the APOE ε4 allele relate to
the shape deformity and/or volumetric changes in the CA1 subfield. Further research is needed to
identify if the relationship between APOE ε4 allele, CA1 atrophy, and delusions is specific to AD,
all disorders that present with delusions, or merely correlational to the presence of AD. The aims
of this study are to examine the association of delusions with CA1 volumes and the presence of
APOE ε4 alleles within an AD population.

1.2 Alzheimer’s disease (AD)
Alzheimer’s disease (AD) is the most common type of dementia; a progressive,
neurodegenerative disease that is associated with impaired memory and cognitive decline
(American Psychiatric Association, 2013). Other types of dementias include Lewy Body dementia
(LBD), vascular dementia, and frontotemporal dementia, each of which make up roughly 5-10%
of individuals diagnosed with dementia. In addition to its progressive neurocognitive impairment,
AD is categorized by the presence of beta-amyloid plagues and tau neurofibrillary tangles within
the brain (Ballatore et al., 2007; Dickson & Vickers, 2001; Masters & Selkoe, 2012). AD can also
present with motor deficits, and neuropsychiatric symptoms such as depression, irritability, and
psychosis (hallucinations and delusions). It is estimated that psychosis prevalence in AD is roughly
50% of cases with delusions being present is roughly one-third of all AD patients (Fischer &
Sweet, 2016; Murray et al., 2014; Ropacki & Jeste, 2005). The presentation of psychosis in AD
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can be difficult to diagnose partially because individuals with AD may be completely free of
psychosis for years prior to the first noted presentation (Fischer & Sweet, 2016b; White &
Cummings, 1996). Psychosis presentation in AD is more common in the middle to later stages of
the disease and therefore, may be presenting alongside more severe neurocognitive symptoms
(Murray et al., 2014; Sweet et al., 2003b). In addition, psychosis in AD is often associated with
adverse outcomes including aggression, agitation, functional impairment, behavioral symptoms,
rapid cognitive decline, mortality, and increased caregiver burden (Murray et al., 2014). Within
dementia, delusions have been associated with distinct neurobiological mechanisms including
abnormalities on fronto-dementia (FTD) genes (C9orf72, MAPT, GRM) and more severe disease
severity (Kumfor et al., 2022). Therefore, examining the specific neural and genetic underpinnings
of delusions in AD may help in understanding the mechanisms behind this severe sub-presentation
of dementia.

1.3 Apolipoprotein (APOE) ε allele
The APOE gene is polymorphic and has three different variants: APOE ε2, APOE ε3, and
APOE ε4, see Table 1 for more details. Two specific single nucleotide polymorphisms (SNPs)
found within the APOE gene, rs429358 and rs7412, of chromosome 19q13.32 with the three
different variants all having different methylation levels. Every individual has two copies of the
APOE gene, leading to six possible combinations. The function of the APOE gene is largely lipid
transport and cholesterol homeostasis. Dysregulation of these functions, lipid metabolism and
homeostasis, has been ascertained as a contributor of degenerative disorders (Bleasel et al., 2014;
Sultana et al., 2013). In addition to lipid transport, the APOE gene has been implicated in increased
inflammation responses (less injury repair), decrease in synaptic signaling, mitochondrial function,
and degradation of the blood brain barrier integrity. The current theory is that specific APOE
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genotypes relate to adverse or slowed reactions to injury. For example, normal aging can be
thought of as a cumulation of tiny injuries or degeneration and therefore, APOE ε4 allele is related
to less repair as the brain ages (Reinvang et al., 2013; Washington & Burns, 2016). Individuals
with the APOE ε4 allele also have higher levels of plasma and neuronal cholesterol (de Chaves et
al., 2008; Jeong et al., 2019). Specific to APOE ε4 allele, individuals with at least one copy of this
variant have an increased risk of developing Alzheimer’s disease (AD) and coronary artery disease
(CAD) (Mahley, 2016; Stocker et al., 2018).
Table 1. APOE variants.
APOE variant
ε4
ε3
ε2

SNP alleles
rs429358
C
T
T

rs7412
C
C
T

APOE Genotype
ε4ε4
ε3ε4
ε2ε4
ε3ε3
ε2ε3
ε2ε2

rs429358
CC
TC
TC
TT
TT
TT

rs7412
CC
CC
TC
CC
TC
TT

The APOE ε4 allele accounts for approximately 50-60% of the genetic variation in AD (Liu
et al., 2013). Possession of a single copy of the APOE ε4 allele is related to a three-fold risk of
developing AD, while the ε4/ε4 genotype is associated with a 14-fold increase in disease risk
(Belloy et al., 2019; Corder et al., 1993). The APOE ε4 allele is also associated with a decreased
age of AD onset and decreased survival (Belloy et al., 2019; Corder et al., 1993). The association
between APOE ε4 and AD is thought to be related to the increase in amyloid beta aggregation and
toxicity and reduction of amyloid beta clearance, all of which lead to a buildup of amyloid plagues,
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the common presentation of AD. The APOE ε4 allele is associated with an earlier presentation of
amyloid, further supporting its role in early-onset AD (Kanekiyo et al., 2014; Tachibana et al.,
2019). Individuals with one or two ε4 alleles have the most amyloid beta and those with the APOE
ε2 allele(s) have the least amount of amyloid beta (Kanekiyo et al., 2014). Therefore, the APOE
ε2 allele is assumed to be a protective factor against AD and even other disorders (e.g., mood
disorders).

APOE and the brain
APOE is reported in high levels in the temporal lobe, putamen, hippocampus, caudate,
precentral gyrus, and cerebellum and these regions may aid in determining the mechanisms in
which APOE ε4 relates to brain dysfunction (Digney et al., 2005b; Flowers & Rebeck, 2020;
Holtzman et al., 2012). Structural MRI studies have found an association between the APOE ε4
allele and hippocampal volume loss in both smaller baseline volume and higher rate of gray matter
loss in AD (Cacciaglia et al., 2018; Schuff et al., 2008; Taylor et al., 2014b). In a longitudinal
study, homozygous APOE ε4 carriers had significant unilateral atrophy in the head of the right
hippocampus compared to heterozygous APOE ε4 carriers (Li et al., 2016). More specifically,
carriers of the APOE ε4 allele exhibit greater hippocampal volume loss, specifically in the Cornu
ammonis (CA1) subsection of the hippocampus, known for novelty detection and autonoetic
consciousness (Bartsch et al., 2011; Kerchner et al., 2014; Padurariu et al., 2012). Less gray matter
concentration was also identified in carriers of the APOE ε4 allele(s) in both the posterior cingulate
and amygdala (Haller et al., 2017).
Regarding diagnoses, the APOE ε4 allele has also been implicated in a variety of disorders
and symptom phenotypes; individuals with schizophrenia, psychosis phenotypes of AD, mood
disorders, and Lewy body dementia (Burke et al., 2016; Digney et al., 2005; Jonas et al., 2019;
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Zubenko et al., 1996). An increased odds ratio of 3.11 [95% CI 1.21-8.01] between the APOE ε4
allele and delusions was identified in individuals with Alzheimer’s disease (Spalletta et al., 2006).
However, this association has not been consistently found in more recent research (del Prete et al.,
2009; Qian et al., 2018). APOE ε4 also appears to play a role in cognition, specifically attention
and memory. In individuals with Parkinson’s disease, APOE ε4 is also related to faster (and
overall) cognitive decline but an increased risk of dementia was not consistently identified (Kurz
et al., 2009; Mata et al., 2014; Paul et al., 2016). In middle-aged adults without dementia, the
APOE ε4 allele was related to impairments in the ability to shift attention from irrelevant stimuli
and in spatial working memory tasks (Greenwood et al., 2005). These findings suggest that the
APOE ε4 allele may moderate selective attention and spatial working memory even in cognitively
typical adults.
As mentioned previously, APOE ε4 allele possession is related to a higher risk of AD, but
in addition the APOE ε4 allele is related to worse overall AD symptoms, increased inflammation
responses, decrease in synaptic signaling, and lower injury recovery (Flowers & Rebeck, 2020). It
has also been hypothesized that APOE ε4 allele is related to slower brain development as presence
of the allele was negatively related to temporal lobe gray matter in neonates (Taylor et al., 2014a).
A reduction in gray matter may indicate lower tissue reserve, which may be part of the association
with AD but could also explain the association between the APOE ε4 allele and brain disorders in
general. We hypothesize that, given its negative implications especially in neural injury recovery,
the ε4 allele may also moderate the associations of gray matter atrophy (specifically in the
hippocampus) and neuropsychiatric symptoms observed in AD.
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CA1 Subfield of the Hippocampus
The subfields of the hippocampus have unique cytoarchitecture and each subfield is
thought to play distinct roles with different cognitive processes. The hippocampal subfields include
the cornu ammonis (CA1, CA2, and CA3), dentate gyrus, the presubiculum, and the subiculum.
See Figure 1 originally printed in (Travis et al., 2014).
Figure 1. Segmentation of the Hippocampal subfields from Travis et al., 2014.

Fig. 1. Figure originally printed in Travis et al., 2014. Segmentation of the
hippocampus (HC) subfields within HC sub-regions is shown on T2-weighted
Fast Spin Echo (FSE) images using inverted contrast: coronal views of the
hippocampal body (a and b); hippocampal head (c and d); hippocampal tail (e
and f). Abbreviations: CA1–3=cornu ammonis (shown in red); DG=dentate
gyrus (shown in blue); sub=subiculum (shown in green); SLM=stratum
lacunosum-moleculare
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Spanning both the anterior (head) and posterior (tail) hippocampal regions, the Cornu
ammonis (CA1) has been implicated in novelty detection, information input comparison, and
autobiographical memory. More specifically, the CA1 region has most notably been studied in
autonoetic consciousness, the ability to reflect on one’s own life and experiences and perceive
continuity from past, present, and future events (Bartsch et al., 2011a). Given its hippocampal
placement and its role in autobiographical memory, CA1 shape deformity has been consistently
implicated in AD and other dementias (Padurariu et al., 2012). The CA1 has also been implicated
in individuals with schizophrenia (Schobel et al., 2009; Zierhut et al., 2013).
Pyramidal cell death in the CA1 was previously hypothesized as a primary cause of paranoid
delusions (Krieckhaus et al., 1992). In schizophrenia, CA1 volume reduction and shape deformity
have been negatively associated with overall delusion severity and hallucination severity (Zierhut
et al., 2013). Lower neuron counts in the CA1 were related to misidentification delusions (Förstl
et al., 1994) and focal brain lesions were identified in the CA1 regions of individuals who presented
with Capgras delusion (Feinberg & Keenan, 2005). It had previously been reported that CA1
connectivity was related to overall positive symptoms (Schobel et al., 2009). Theoretically,
hyperactivation of the CA1 may relate to a disturbed processing of information, and that may be
predictive of positive symptoms. It is possible that this subregion is broadly related to psychosis
and not specifically, delusions. The atrophy observed in the CA1 may be caused by hyperactive
hippocampal states that ultimately result in neuronal or glial loss throughout the course of the
disease. If this is the order of operations, then this atrophy could be identified in a host of disorders
the relate to hyperactivity in the hippocampus, not just AD. There is some evidence for association
between the dopamine-related gating at CA1 and delusions of misidentification, a common
delusion type observed in AD (Ismail et al., 2012).
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1.4 Delusions
Delusions are categorized as fixed, false beliefs that are maintained despite contrary evidence
(American Psychiatric Association, 2013). Referred to as a form of psychosis, delusions are a
hallmark of schizophrenia and one of the main diagnostic criteria for the disorder (American
Psychiatric Association, 2013; Maher, 2006). Delusions also present transdiagnostically, in
neurodegenerative diseases, nervous system disorders, stroke patients, traumatic brain injuries, and
other psychiatric disorders. There is even, albeit rare (current prevalence rate of 0.2%), a
standalone diagnosis of delusional disorder that can remit naturally, maintain with reduced
intensity, or result in a change of diagnosis to schizophrenia (American Psychiatric Association,
2013; Opjordsmoen, 2014). Delusions, regardless of primary disorder, are associated with
increased caregiver burden, poorer medication adherence, and overall, worsening prognosis across
disorders and can severely impact functioning and independent living (Altamura et al., 2018;
Fischer & Sweet, 2016; Ismail et al., 2011; Warren et al., 2018; Whitehead et al., 2012).
Delusion type falls broadly into twelve different categories with some discrepancies:
persecutory, jealousy, grandiosity, religious, delusion of reference, erotomania, guilt, somatic, and
passive delusions such as, thought withdrawal, thought insertion, thought broadcasting, and the
delusion of being controlled. There are additional categories of delusions that are more specific
and common in Alzheimer’s disease, such as Capgras delusion (believing family members are
replaced by an identical imposter) and Othello’s syndrome (delusional jealousy about family
members) (Moro et al., 2013). Different types of delusions may be associated with co-occurring
symptoms (e.g., mood states) and overall clinical presentations that are etiologically
heterogeneous. In AD, the most common types of delusions are persecutory (or paranoia) and
delusions of misidentification (e.g., Capgras delusion). Furthermore, different types of delusions
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may indicate different underlying psychopathological constructs (e.g., deficits in self-monitoring
versus deficits in source monitoring (Blakemore et al., 2000; Corlett et al., 2010).

Current Hypotheses on the Development of Delusions
Delusions: The Dopamine Dysfunction Hypothesis. The salience network involving the
bilateral anterior insula and anterior cingulate cortex has been implicated in error monitoring and
processing of salience pathway. In functional studies, the anterior insula cortex and the anterior
cingulate cortex are activated during errors in performance and error awareness (Harsay, Spaan,
Wijnen, & Ridderinkhof, 2012; Klein et al., 2007; Ullsperger et al., 2010). Specifically, the insulacortico-thalamic circuit, including the dorsal and ventral areas of the anterior insula, is responsible
for both error awareness and the processing of salience (Harsay, Spaan, Wijnen, & Ridderinkhof,
2012). Psychosis has been shown to be associated with a dysfunction of the dopamine-dependent
process of salience attribution (Kapur, 2003; Maia & Frank, 2017). Specifically, an increase in
striatal dopamine synthesis capacity is related to psychosis progression (Howes et al., 2011). In
schizophrenia, however, the disruption may be further explained by a combination of increased
dopaminergic activity for irrelevant stimuli and a decrease in dopaminergic activity regarding
situation relevant stimuli (Maia & Frank, 2017). The mechanism of antipsychotic medications,
mostly through dopamine (D2) antagonism (B. Li et al., 2016), suggests a causal relationship
between psychosis and dopaminergic disruptions. However, it should be noted that this dopamine
dysregulation model has mostly be developed in the context of psychosis in schizophrenia.
Similarly in Alzheimer’s disease, an excess of striatal dopamine D2/3 receptors was found to be
related to delusion presence (Reeves et al., 2012). Levodopa (L-dopa), a precursor to dopamine, is
the gold-standard medication for Parkinson’s disease, though may result in the formation of
delusions and hallucinations (Ruggieri et al., 1997; Swick & Walling, 2005). A recent study found
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that 81% of Parkinson’s disease patients developed psychosis after being on a dopamine
replacement therapy (e.g., levodopa) (Dave et al., 2020). However, this association is not specific
to delusions, such that there are remaining questions as to specificity of the relationship between
dopamine dysregulation and delusions.
The mesolimbic pathway is a collection of dopaminergic neurons beginning at the ventral
tegmental area in the midbrain and connecting to the ventral striatum (including the nucleus
accumbens) of the basal ganglia in the forebrain. The release of dopamine into the nucleus
accumbens regulates motivational salience, influences drive and behavior, and reward-based
learning whereas release of dopamine in the dorsomedial prefrontal cortex is more related to effort
learning (e.g., cost and benefits) (Chong, 2018; Kapur, 2003). The current understanding is that
disruptions in the dopaminergic system may result in misread salient information, attention to
irrelevant stimuli, and ultimately, disruptions to reward-related behavior (Howes & Nour, 2016;
Kapur, 2003; Winton-Brown et al., 2014). Individuals with schizophrenia and psychosis have been
shown to assign overt salience to contextually irrelevant stimuli, potentially because of this
disruption of dopamine release (Kapur et al., 2005; Katthagen et al., 2022; Menon et al., 2022).
This disruption may explain (at least initially) the divergence of belief formation and belief
updating into psychosis formation. Therefore, this framework may begin to explain not only
formation of delusions but hallucinations as well.
Delusions: Deficits in Error Monitoring. Delusions have previously been conceptualized
as the result of defects in error monitoring, perhaps related to a disruption in dopaminergic
pathways (Corlett et al., 2010; Krummenacher et al., 2010). Deficits in the ability to differentiate
information-bearing patterns from noise result in noise taken in as salient information, also referred
to as deficits in signal detection. Corlett and colleagues described this deficit as a two-factor model
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(Corlett et al., 2010). First, the predictor error, or a discrepancy between the brain’s prediction of
a stimulus and the actual perception of that stimulus, occurs, and second, abnormal stimulus
information is integrated into previous knowledge (Corlett et al., 2010). More specifically, the
discrepancy between prediction and stimulus perception results in incorrect attention towards
potential explanatory cues and subsequently, learning of misrepresentations of the environment,
resulting in the formation of a delusion (Corlett et al., 2010; Corlett & Fletcher, 2015). Individuals
with schizophrenia have been shown to have impaired error monitoring and importantly, defects
in error awareness (Mathalon et al., 2002). Prediction errors, in a deficit model for psychosis, have
been associated with the dorsolateral prefrontal cortex and the right middle/frontal gyrus (Griffiths
et al., 2014). Previous structural studies have also implicated the left inferior frontal gyrus (IFG)
in error monitoring (Mitchell et al., 2009; Sharot & Garrett, 2016). As previously mentioned, the
dopaminergic system also plays a role in signaling errors related to reward (or salience) prediction
(Schultz & Dickinson, 2000). In functional studies, the anterior insula cortex and the anterior
cingulate cortex are activated during errors in performance and error awareness (Harsay, Spaan,
Wijnen, & Ridderinkhof, 2012; Klein et al., 2007; Ullsperger et al., 2010). Specifically, the insulacortico-thalamic circuit, including the dorsal and ventral areas of the anterior insula, is responsible
for both error awareness and the processing of salience (Harsay, Spaan, Wijnen, & Ridderinkhof,
2012). Given the study populations, it is unclear if this theory explains all delusion formation or
relates only to delusions in patients with schizophrenia.
Delusions: Cognitive Biases. Additional theories have been postulated about delusions
being a form of cognitive bias. This theory states that the maintenance of delusional thinking
requires a two-sided approach, or bias, to incoming information. There is a predilection for
information supporting the delusion (confirmatory evidence), and an avoidance (or rejection) of
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evidence not supporting the delusion (non-confirmatory evidence) (Moritz & Woodward, 2006;
Woodward et al., 2006). Specifically, cognitive biases such as jumping to conclusions, biases
against disconfirming evidence (BADE), and liberal acceptance are more commonly seen in
individuals with schizophrenia and delusions than healthy populations without psychosis (Moritz
& Woodward, 2006; Veckenstedt et al., 2011).
Functional studies found the jumping-to-conclusion bias was associated with the
dopaminergic reward system and the posterior cingulate cortex (Andreou et al., 2018). Bias against
disconfirming evidence (BADE) was associated with increased visual network activity and
reduced default mode network (DMN) activity when processing confirmatory evidence, and
reduced activation in the orbitofrontal cortex, inferior frontal gyrus, and parietal cortex when
processing disconfirming evidence in individuals with schizophrenia with delusional ideation
(Lavigne et al., 2020).
These cognitive bias theories have all been suggested as separate explanations for the
etiology of delusions. These theories may help to explain why delusions feel “real” to the
individual and do not elicit scrutiny or questioning even in the face of contrary evidence. Together,
the deficits in error monitoring and cognitive biases theories present the two main stages of
delusions: formation and maintenance. In other words, the delusion begins with an error in the
processing of stimuli (a default) followed by avoiding the contradictory evidence while seeking
out confirming evidence (a bias) to maintain the delusion. However, the theories have largely only
been examined with individuals with schizophrenia or healthy volunteers using cognitive-based
tasks (e.g., oddball task, antisaccade task) that represent circuits that underlie delusions. It remains
unclear if these tasks activate the same the networks involved in delusion formation and
maintenance. In addition, as most studies examining the neurobiology and neuroanatomy of
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delusions focus on schizophrenia, it remains unclear if these theories of etiology and related
circuitries generalize across the different diagnoses where delusions are present, such as AD.
Although delusions can occur in a multitude of disorders, there may be unique etiology to delusions
in AD given that psychosis presentation in AD typically occurs in the middle to later stages of the
disease (Sweet et al., 2003a). The delayed onset of delusions (as opposed to at first diagnosis) may
indirectly relate to the course of AD and the degradation of cortical structures.

1.5 Delusions: Gray Matter Alterations
Across diagnoses, structural studies identified that delusions were related to varying degrees
of alteration in the frontal and temporal regions (Rootes-Murdy et al., 2022). Although, there were
some inconsistencies in the directionality of the gray matter alterations (Zhu et al., 2016), delusions
were most associated with gray matter reductions in the dorsolateral prefrontal cortex (in
individuals with SZ, bipolar disorder (BP), and AD), left claustrum (SZ and AD), insula (SZ, BP,
and AD), thalamus (SZ and AD), superior temporal gyrus (SZ, BP, and AD), and middle frontal
gyrus (SZ, BP, AD, and Parkinson’s disease), and the hippocampus (SZ and AD). The individual
functions associated with these regions may explain the relationship with delusions.
The claustrum is related to cognitive control, multi-sensory integration, consciousness, and
task switching as well as cortically connected to the insula and the default mode network (Krimmel
et al., 2019). The insula relates to proprioception and the sense of self, self-awareness, more
specifically, the posterior part of the insula is related to attention to and processing of salience
(Craig, 2002; Harsay, Spaan, Wijnen, & Ridderinkhof, 2012). The hippocampus is primarily
responsible for both short-term and long-term memory storage and retrieval (Squire, 1992) as well
as declarative memory, recollection of recognition memory, episodic memory, and familiarity
(Bird, 2017; Brown & Aggleton, 2001; Kim, 2015) and along with the amygdala, salient
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information processing (Zheng et al., 2017). The posterior region of the superior temporal gyrus
(specifically Wernicke’s speech area, BA 22) is associated with auditory processing (Howard et
al., 2000), and the caudal region relates to sentence comprehension (Hamilton et al., 2018). The
thalamus serves as a relay station between internal and external information as well as being
structurally related to the hippocampus, limbic system, and fornix. Specifically, the thalamocortical neurons are responsible for receiving external sensory information and relaying it
upstream (Torrico & Munakomi, 2019) whereas the cortico-thalamo-cortical loop has been
implicated in the maintenance of consciousness and attention to incoming visual stimuli (Trapp et
al., 2012).
However, it should be noted that these identified regions are also typically implicated in
psychiatric disorders, neurodegenerative disorders, and nervous system disorders like Parkinson’s
disease and may be related to either the neural deterioration commonly seen in psychiatric
disorders (DelBello et al., 2004; Gupta et al., 2015; Kempton, 2011; Lorenzetti et al., 2009; Torres
et al., 2016), or the genetic and neural overlap amongst schizophrenia and bipolar disorder with
psychosis (Tamminga et al., 2017), and less related to delusions specifically. Therefore, these
regions can be viewed as a starting point for examining the cortical alterations associated with
delusions but are not fully explaining the etiology of delusions.

1.6 Delusions in Alzheimer’s Disease: Gray Matter Alterations
One cortical region that has consistently been altered in AD is the hippocampus, known for
its role in short and long-term memory, memory encoding, social interactions, and flexible
cognition (Li & Liu, 2019; Möller et al., 2013). Importantly, the hippocampus is thought to be one
of the first brain regions that is affected in AD. However, by the time most patients are diagnosed
with AD, multiple brain regions can be and typically are altered, whether it be from the disease or
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natural aging, making it difficult to differentiate primary from secondary sites of dysfunction.
These areas are also differentially vulnerable to disease (and aging) mechanisms. As previously
mentioned, structural MRI studies have found that delusions in AD are correlated with less gray
matter in the right frontoparietal, left frontal lobe, right hippocampus, and the left claustrum (Bruen
et al., 2008; Serra et al., 2010a). Specific to women with Alzheimer’s disease and paranoid
delusions, there was noted atrophy in the left lateral and medial orbitofrontal and superior temporal
regions (Whitehead et al., 2012). In addition, there was also less gray matter in the sensorimotor
area (Brodmann’s Area (BA) 6), left precentral gyrus (BA 6), and frontal eye fields (BA 8) in
individuals with delusions and more accelerated atrophy in the temporal middle gyri (BA 20 and
21, respectively) when compared to individuals without delusions (Qian, Schweizer, et al., 2019a).
In a longitudinal study of AD and delusions, regional gray matter decreases were found in
the insula, precuneus, cerebellum, superior temporal gyrus, right posterior cingulate, thalamus, and
left parahippocampal gyrus in individuals who developed delusions (Fischer & Sweet, 2016).
Delusions of misidentification and mixed delusions were also related to reduced cortical volume
bilaterally in the parahippocampal gyrus (McLachlan et al., 2018). In addition, treatment response
to risperidone (for delusions) was significantly associated with larger volumes in the temporal lobe
and limbic system (e.g., left amygdala and left parahippocampal gyrus) (Jeong et al., 2021). In the
Alzheimer’s Disease Neuroimaging Initiative (ADNI) database, individuals who subsequently
developed delusions had gray matter loss in the bilateral parahippocampal gyri and left
hippocampus, right anterior cingulate cortex, and the posterior regions of the default mode network
(DMN) (Manca et al., 2022). Delusions across multiple dementias were related to gray matter
reductions in the dorsolateral frontal lobes, specifically the superior frontal gyrus and the right
posterior lateral temporal lobe (Graff-Radford et al., 2012a). Delusions in Alzheimer’s disease
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appear to relate to unique cortical changes, namely in the frontal lobe as well as the temporal
regions and limbic system, and subcortical areas relating to the dopaminergic pathways, all of
which are not explained by AD alone. However, the exact mechanisms and etiology of these
cortical alterations are still not fully understood. See Table 2 for more specific details.
The combination of a structural study with the examination of the genetic effect from the
APOE ε4 allele will add to our understanding of the mechanisms by which this allele relates to
delusions in AD and will inform treatment options for individuals with delusions by highlighting
a neural underpinning of the symptom. Our hypothesis was that the ε4 allele has a pleiotropic
effect, relating to multiple symptoms and clinical phenotypes, in both AD cognitive status and
presence of delusions by way of gray matter volume in the CA1 subfield. We hypothesize that this
effect is moderating two pathways 1) the relationship between CA1 volume and the presence of
delusions and 2) the relationship between CA1 volume and AD cognitive status.

DELUSIONS IN ALZHEIMERS DISEASE

19

Table 2. Review of Structural Imaging Studies of Alzheimer’s disease and Delusions
Study

Sample Size

Delusion
assessment

Delusion
Type

Direction
of Findings

Imaging phenotype
associated with delusions

Notes

Longitudinal
study

(Fischer & Sweet,
2016)

MCI (7); AD
(17)

NPI-Q

All

↓ in GM

L precuneus, insula,
cerebellum, L superior
temporal gyrus, L
parahippocampal, R
thalamus, R posterior
cingulate

(Graff-Radford et
al., 2012b)

DLBD (5);
AD (6);
bvFTD (3);
D-(14)

UPDRS-TD

Othello
syndrome

D+ < D-

Dorsolateral frontal lobes,
superior frontal gyri, R
posterior lateral temporal lobe

(Qian, Schweizer,
et al., 2019b)

AD (59);
D+ (23), D(36)

NPI-Q

Not
specified

↓ in GM

Precentral and middle frontal
gyri, SMA

Significant
delusion ×
time
interaction

NPI-12

All

↓ in GM

R hippocampus

5% D+

NPI

Paranoid

↓ in GM

L medial orbitofrontal, L
superior temporal, L insula

Results only in
females

(Serra et al., 2010b)
(Whitehead et al.,
2012)

AD (27)
MCI (19)
HC (23)
AD (113);
D+ (23)

All results used T1 scans. MCI: mild cognitive impairment; AD: Alzheimer’s disease; DLBD: Dementia with Lewy Body disease; bvFTD:
behavioral variant of Frontotemporal dementia; D+: individuals with delusions; D-: individuals without delusions; NPI-Q: Neuropsychiatric
Inventory-Questionnaire; UPDRS-TD: Unified Parkinson’s Disease Rating Scale-Tremor Dominant; L: left; R: right; GM: gray matter.

DELUSIONS IN ALZHEIMERS DISEASE

20

AIM I: EXAMINE THE RELATIONSHIP BETWEEN CA1 VOLUME, PRESENCE OF
DELUSIONS, AND APOE ε4 STATUS

2.1 Aim and hypothesis
The overlap in gray matter alterations identified in the hippocampus, specifically in the CA1
region, in AD, delusions, and APOE ε4 status indicate potential support for an association between
ε4 status and delusions. The goal of this project was to understand the relationship between the
CA1 structure and the ε4 allele and determine if that relationship moderates the presence of
delusions in AD. In this study, the first aim was to examine the relationship between the CA1
volumes and APOE ε4 status in individuals with delusions, and to determine if that relationship
was significantly different from individuals without delusions.
We hypothesized that smaller CA1 volumes would relate more strongly to presence of
delusions in those with the ε4 allele(s) when compared to those without an ε4 allele. We
hypothesized the same moderation effect would be identified between the relationship of CA1
volume, AD cognitive status, and the APOE ε4 status such that in those individuals with ε4
allele(s), small CA1 volumes would relate to worse AD cognitive status (as measured by the
MMSE). More specifically, we hypothesized that individuals with delusions would have smaller
CA1 volumes compared to individuals without delusions and that CA1 volumes would be
moderated by the APOE ε4 status.
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2.2 Methods
2.2.1 Participants
For this study, we utilized two open-access Alzheimer’s disease and aging datasets. The
Open Access Series of Imaging Studies (OASIS) is a large-scale collection of imaging data from
several projects originally collected to examine the effects of healthy aging and Alzheimer’s
disease (AD) (Marcus et al., 2007). The data were collected over the course of 30 years including
both cognitively normal adults and adults at various stages of cognitive decline. The current project
used the OASIS-3 data release that included structural MR sessions, clinical assessments, and
biological data (LaMontagne et al., 2019). There were a total of 1,377 participants aged 42 to 95
years old, including cognitively typical individuals (N = 755) and individuals diagnosed with
early-stage AD dementia and other various stages of cognitive decline (N = 622) (LaMontagne et
al., 2019). This most recent data release has structural (MRI) imaging data, neuropsychological
testing, including the Neuropsychiatric Interview-Questionnaire (NPI-Q), and APOE genotyping
completed (LaMontagne et al., 2019). Data were collected under the approval of local institutional
review boards and all participants provided informed consent. The recruitment and informed
consent process have both been previously described in the literature (LaMontagne et al., 2019).
The Alzheimer’s Disease Neuroimaging Initiative (ADNI) is a longitudinal multicenter
study designed to develop biomarkers for Alzheimer’s disease by examining clinical, imaging,
genetic, and biochemical correlates of the disease’s progression (Weiner et al., 2010). Through the
multiple study arms, ADNI has enrolled roughly 400 individuals with AD, 1,000 individuals with
mild cognitive impairment, and 480 cognitively typical individuals (Weiner et al., 2010, 2017).
For both datasets, there were initial diagnoses assigned at the screening visit. These
diagnoses were confirmed at the baseline visit using clinical and neuropsychological testing.
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Diagnoses were potentially re-classified, if applicable, upon subsequent visits. In both datasets,
Alzheimer’s disease diagnoses were diagnosed clinically and characterized using the Clinical
Dementia Rating (CDR) scale (Morris et al., 2001). ADNI stated that participants needed to have
a score of greater than 0.5 to be classified as AD and OASIS used a score of greater than zero (0).
For the purposes of this study, the diagnoses listed in the ADNIMERGE.csv were used for the
ADNI dataset and the diagnoses listed in “dx1” column were used for the OASIS-3 dataset as of
August 1, 2022. In total, there were 206 individuals from the ADNI dataset and 279 from the
OASIS dataset that had 1). an Alzheimer’s diagnosis and 2). a high quality T1 structural MRI
image. See Table 3 for the participant information as it relates to this current study.

Table 3. Alzheimer’s Disease (AD) Participant Information by Study.
OASIS3

ADNI

Total

279

206

485

Age (M; SD)

74.02 (8.09)

74.85 (7.67)

74.34 (7.89)

Males (%)

138 (49.46%)

103 (50%)

241 (49.69%)

Caucasian

222 (85.06%)

182 (93.81%)

404 (88.79%)

African-American

39 (14.94%)

6 (3.09%)

45 (9.89%)

Asian

0 (0%)

4 (2.06%)

4 (0.88%)

Selected > 1 Race

0 (0%)

2 (1.03%)

2 (0.439%)

0 ε4 alleles

119

33

152

1 1 ε4 allele

137

135

272

2 ε4 alleles

23

38

61

Delusions (%)

35 (12.54%)

38 (18.45%)

73 (15.05%)

MMSE (M; SD)

21.56 (6.28)

23.52 (2.69)

22.43 (5.09)

N

#Race

(%)

APOE ε4 alleles

#

Missing reports from both OASIS (N = 18) and ADNI (N = 12). Percentages
calculated based off total reported values.
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2.2.2 Neuroimaging data
MRI images from both datasets had already been collected and all images had been graded
for quality assurance by the ADNI investigators. The MRI scans are all T1-weighted MR images.
For ADNI, MRI acquisition was completed following the ADNI acquisition protocol (Jack et al.,
2008). Briefly, advanced imaging (diffusion imaging, resting state fMRI, or arterial spin labeling)
was included depending on scanner manufacturer. The primary acquisition for the T1 sequence
was an accelerated sagittal IR-FSPGR (Repetition Time (TR) = 7.36 ms, Echo Time (TE) = 3.05
ms, Inversion Time (TI) = 400 ms, Flip Angle (FA) = 11 degrees, Voxel Size (VS) = 1 X 1 X 1
mm, Matrix Size = 256 X 256, Field of View (FOV) = 256, 196 slices). For OASIS, MRI
acquisition was completed following the OASIS protocol (LaMontagne et al., 2019). All scans
were conducted by the Knight Alzheimer Research Imaging Program at Washington University.
OASIS included T1-weighted MR images that were collected on either Siemens 3T (using a 20channel head coil) or 1.5T (using a 16-channel head coil) scanners. More details on the OASIS
MRI protocol can be found on their website (https://www.oasis-brains.org).
Preprocessing of imaging data. Both ADNI and OASIS are longitudinal datasets that have
collected multiple scans from participants. For the purposes of this study, only the most recent
MRI scans (determined by visit date) were utilized for analysis. T1-weighted structural MRI data
from both the ADNI and OASIS datasets were preprocessed with the FreeSurfer software suite
v7.1.1 (https://surfer.nmr.mgh.harvard.edu/). The FreeSurfer automated pipeline consists of
several processing steps, including skull stripping, Talairach transformation, subcortical structure
labelling, surface extraction, spherical registration, and cortical parcellation. In brief, T1-weighted
images are motion-corrected and non-brain tissue is removed using a hybrid watershed/surface
deformation procedure. The images are automatically registered to Talairach space and segmented
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into subcortical white matter and gray matter structures. This automated process and protocol have
been previously described in the literature (Dale et al., 1999; Fischl et al., 2002). To assure data
quality, all MRI images were run through FreeSurfer’s quality assessment (QA) tool
(https://surfer.nmr.mgh.harvard.edu/fswiki/QATools) and the images with poor QA (ADNI: N =
3; OASIS: N = 19) were removed from all analyses. The T1-weighted MR images were run
through hippocampal segmentation (Iglesias et al., 2015). This tool uses a probabilistic atlas built
with ultra-high resolution ex vivo MRI data (~0.1 mm isotropic) to produce an automated
Figure 2. Multi-slice view of hippocampal segmentation in Freesurfer v7.

segmentation of the hippocampal substructures (see Fig. 2 originally from the Freesurfer website:
https://surfer.nmr.mgh.harvard.edu/fswiki/HippocampalSubfieldsAndNucleiOfAmygdala).

For

the purposes of this Aim, we followed the guidelines and cautions outlined in (Wisse et al., 2021),
and only examined the CA1 subfield as a sole region of interest. The CA1-head and CA1-body
volumes were summed to generate a total CA1 volume for both the left and right CA1.
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2.2.3 Genotyping
For the ADNI APOE genotyping, APOE genotyping was performed at the time of participant
enrollment. The two SNPs (rs429358, rs7412) that define the ε2, ε3, and ε4 alleles, are not on the
Human610-Quad BeadChip, and therefore were genotyped using DNA extracted by Cogenics
from a 3 mL aliquot of EDTA blood. For the OASIS APOE genotyping, APOE genotyping was
performed with blood samples using PCR amplification of a 244-bp fragment followed by
restriction enzyme Hhal digest (Hixson & Vernier, 1990; LaMontagne et al., 2019). Genomic DNA
was extracted from blood samples using QIAmp DNA blood mini kits from Qiagen Inc. (Valencia,
CA). APOE genotyping was performed using PCR amplification of a 244-bp fragment followed
by restriction enzyme HhaI digest22.

2.2.4 Assessments
MMSE. Both datasets included the Mini-Mental State Exam (Folstein et al., 1975) , an 11question test designed to test various aspects of cognitive functioning in the elderly. For those with
a college education, a score below 24 is considered abnormal and possible mild cognitive
impairment. For the purposes of this study, we used the total MMSE score as an indicator for
cognitive status as it relates to Alzheimer’s disease presentation. In the ADNI dataset, the average
MMSE score was 23.52 (SD = 2.69) and the range was between 17 and 30. In the OASIS dataset,
the average MMSE score was 21.56 (SD = 6.28) and the range was between 1 and 30 (all zeros
were removed from analyses).
NPI-Q. A common assessment for psychosis utilized with individuals with AD is the
Neuropsychiatric Interview (NPI) and the adapted, shortened version, the Neuropsychiatric
Interview-Questionnaire (NPI-Q) (Cummings, 1994; Kaufer et al., 2000). The NPI has one
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question regarding delusions, “Does the patient have beliefs that you know are not true (for
example, insisting that people are trying to harm him/her or steal from him/her)? Or has he/she
said that family members are not who they say they are or that the house is not their
home?”. If the patient or caregiver answers “yes” then there are nine follow-up questions asking
about the type of delusion (all focused on paranoia or persecution). The NPI-Q has one question
regarding delusions, “Does the patient have false beliefs, such as thinking that others are stealing
from him/her or planning to harm him/her in some way?”. For the purposes of this study, we used
either of the responses to the above questions (and the subsequent Likert scales of severity and
distress if answered “yes”) to quantify the presence of delusions (yes or no) in our sample. In the
ADNI dataset, there were 39 individuals with AD who endorsed delusions on either one or both
scales. The OASIS dataset only had the NPI-Q completed for participants and there were 40
individuals with AD who endorsed delusions.

2.2.5 Statistical Analyses
We used two hierarchical regression models (one logistic and one linear) to examine if the
APOE ε4 allele is moderating the relationship between 1) CA1 volume and the presence of
delusions and 2) CA1 volume and Alzheimer’s disease cognitive status (as measured by the
MMSE). The analyses were performed in SPSS v28.0.1.1 (IBM Corp. Released 2022. IBM SPSS
Statistics for Windows, Version 28.0. Armonk, NY: IBM Corp) as a block design with age, sex,
and site in Block 1, number of APOE ε4 alleles (0, 1, or 2) in Block 2, CA1 volume and total
hippocampal volume in Block 3, the interaction between centered CA1 volume and centered
number of APOE ε4 alleles (0, 1, or 2) in Block 4. The outcome for the first model was the presence
of delusions (binary coded: 0 (absent) or 1 (present)). The interaction between CA1 volume and
number of APOE ε4 alleles was calculated by first centering CA1 volume and allele number
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around their mean and then computing the product term from those centered predictor variables.
The outcome for the second model was the Mini-Mental State Exam scores (using the same block
design as described above). To control for the two sets of analyses, Bonferroni correction was
applied (α < 0.025 (.05/2)) to our significance threshold for all analyses.
a-priori Power analysis. We ran power analyses to confirm that the sample sizes will yield
results with sufficient effect sizes. For a moderate effect size (0.20 for F test), α level corrected for
two tests at 0.025, the minimal total sample size to achieve power over 90% (assuming equal
sample size in each group) is 108 (54 for each group) (Faul et al., 2007).

2.3 Results
In the ADNI dataset, there were 206 individuals with an Alzheimer’s disease (AD) diagnosis.
Of those 206 individuals, 38 individuals endorsed delusions. In the OASIS dataset, 279
individuals with a primary Alzheimer’s disease (AD) diagnosis. Of those 279 individuals, 35
individuals endorsed delusions. The two groups of individuals, those with delusions and those
without delusions, did not significantly differ on the covariates of age, sex, education attainment,
and MMSE scores. There was also no significant difference in APOE ε4 status (χ2 (2) = 5.076, p
= .079) between the two groups. The groups did significantly differ on race distribution (χ2 (3) =
13.933, p = .003) with individuals without delusions having significantly more individuals
identifying as Caucasian. See Table 4 for more details on group differences.
Table 4. Group Differences for AD Individuals with and without Delusions.
Delusions
No Delusions
t
χ2

p

N

73

392

__

__

__

Age (M; SD)

74.80 (8.16)

74.25 (7.85)

__

.585

Sex (M %)

33 (45.21%)

207 (52.81%)

-0.547
__

1.424

.233
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Race (Caucasian %)

55 (75.34%)

336 (85.71%)

__

13.933

.003*

MMSE

22.80 (3.88)

22.37 (5.28)

-0.803

__

.258

Education

14.97 (3.02)

15.11 (3.12)

0.346

__

.365

Left Hippocampal
volume (mm3)

2506.31
(434.55)

2563.46 (461.69)

0.982

__

.163

Right Hippocampal
volume (mm3)
Left CA1 total
volume (mm3)
Right CA1 total
volume (mm3)

2593.31
(483.76)

2736.20 (523.02)

2.172

__

.015*

477.98 (83.47)

488.30 (94.26)

0.876

__

.191

495.46 (94.67)

527.89 (107.84)

2.407

__

.008*

18 0 ε4 allele

152 0 ε4 allele

37 1 ε4 allele

196 1 ε4 allele

__

5.076

.079

13 2 ε4 alleles

46 2 ε4 alleles

APOE alleles

p value passing Bonferroni corrected α < .025.

*

Delusions. The presence of delusions were not significantly correlated with the left CA1 (r
= -.040, p = .382) volume nor the left whole hippocampus volume (r = -.045, p = .327) but were
significantly corrected with the right CA1 volume (r = -.110, p = .016) and right whole
hippocampus volume (r = -.099, p = .030). See Figure 3 for the left CA1 volume distribution
among individuals with delusions and Figure 4 for the right CA1 volume distribution. Logistic
regression in a block design was used to analyze the relationship between CA1 volumes and
APOE ε4 allele status on the presence of delusions. Age, sex, and site were included in Block 1,
APOE ε4 allele status was included in Block 2, CA1 volume and whole hippocampal volume
were in Block 3, APOE ε4 allele and CA1 volume interaction was Block 4.
For the left CA1, none of the blocks resulted in a significant model. There was an
improvement in the predictive power of the model with the addition of Block 2, the APOE ε4
allele (χ2 = 3.28, p = .070) but the total model did not reach significance (χ2 = 72.87, p = .054).
The additions of Blocks 3 and 4 did not improve the predictive power of the model. See Table 5
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for change in R2 for each additional Block and Table 6 for the total model results. In the final
model, there was no significant association between the left CA1 volume and the presence of
delusions (OR = 0.999 [95% CI: 0.989, 1.009]; p = .870) and there was no significant association
in the interaction between the left CA1 volume × APOE ε4 allele status and the presence of
delusions (OR = 1.000 [95% CI: 0.994, 1.006]; p = .953).
Table 5. Aim I: Cox and Snell R2 and Total Model χ2 Change with Each Block Design.
Cox and Snell
R2

Block χ2

p

Total
model χ2

p

Age, Sex, Site

.165

69.59

.075

69.59

.075

APOE ε4 allele

.172

3.28

.070

72.87

.054

Left CA1 & Whole
hippocampus

.172

0.22

.895

73.09

.074

Left CA1 × APOE ε4 allele

.172

0.003

.953

73.092

.953

Age, Sex, Site

.165

69.59

.075

69.59

.075

APOE ε4 allele

.172

3.28

.070

72.87

.054

Right CA1 & Whole
hippocampus

.176

1.82

.402

74.69

.058

Right CA1 × APOE ε4 allele

.180

2.34

.126

77.03

.048

Left CA1

Right CA1

p value passing Bonferroni corrected α < .025. No results reached significance.

*

For the right CA1, each additional block moderately improved the predictive power of the
model, but no model reached significance. The same association with Block 2, the APOE ε4
allele showed a moderate, but not significant, association with the presence of delusions (χ2 =
3.28, p = .070) with the total model not reaching significance (χ2 = 72.87, p = .054). Block 3, the
right CA1 and right whole hippocampus, resulted in an improvement in the model (χ2 = 74.69, p
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= .058). And the interaction between the right CA1 and the APOE ε4 allele status also improved
the model with an increased R2 but the significance of the total model did not survive Bonferroni
correction (χ2 = 77.03, p = .048). See Tables 5 and 6 for more details.
Individuals with one or more APOE ε4 alleles were 1.58 times more likely to present with
delusions but this association did not reach significance (95% CI [0.945, 2.655]; p = .081). For
the right CA1 volume, there was no significant association between CA1 volume and the
presence of delusions (OR = 0.993 [95% CI: 0.983, 1.003]; p = .161). There was no significant
association in the interaction of the right CA1 volume × APOE ε4 allele status and the presence
of delusions (OR = 1.004 [95% CI: 0.999, 1.009]; p = .132). See Figures 5 and 6 for more details
on the APOE ε4 allele interaction and CA1 volumes within individuals with delusions.

Figure 3. Left CA1 Volumes Across Individuals with and without Delusions.

Fig 3. Results showed no significant difference between individuals with delusions and individuals
without delusions in the left CA1 volume (t = 0.876, p = .191).
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Figure 4. Right CA1 Volumes Across Individuals with and without Delusions.

Fig 4. Results showed individuals with delusions had significantly less right CA1 volumes than individuals
without delusions (t = 2.407, p = .008). However, this association was not significant once accounting for age,
sex, and site.

Table 6. Logistic Regression Block 4 Results Examining Delusions and CA1 Volumes.
B
Wald
OR
p
Left CA1
Age
0.036
1.037
.134
Sex
-0.493
0.611
.160
Site
20.328
1.00
APOE ε4 allele
0.481
1.618
.065
CA1
-0.001
0.999
.870
Whole hippocampus
0.000
1.000
.759
APOE × CA1 Interaction
0.000
1.000
.953
Right CA1
Age
0.025
1.026
.269
Sex
-0.458
0.633
.198
Site
21.228
1.00
APOE ε4 allele
0.460
1.584
.081
CA1
-0.007
0.993
.161
Whole hippocampus
0.001
1.001
.207
APOE × CA1 Interaction
0.004
1.004
.132
Site was included as a categorical variable (df = 52). OR: Odds Ratio. *p value passing Bonferroni
corrected α < .025. No results reached significance.
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Figure 5. APOE alleles and left CA1 volume interaction on the presence of delusions.

Fig 5. Results showed there was no significant interaction between APOE alleles and left CA1 volumes
between individuals with delusions and individuals without delusions.

Figure 6. APOE alleles and right CA1 volume interaction on the presence of delusions.

Fig 6. Results showed the interaction between APOE alleles and right CA1 volumes showed a slight increase
in the average right CA1 volumes of individuals presenting with delusions with each increase of APOE ε4
allele status but this interaction did not survive correction.
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Results of the paired t-test comparing the CA1 subfields, head and body, in both the left
and right CA1 volumes found a significant difference unilaterally in the right CA1 head (t =
2.33, p = .010) and the right CA1 body (t = 2.084, p = .019). The CA1 subfields were also
examined separately using the same logistic regression block model above and there were no
significant associations with either the left (head: OR = 1.007 (95% CI [0.989, 1.026], p = .444;
body: OR = 0.995, 95% CI [0.984, 1.005], p = .332) nor the right subfields (head: OR = 0.993,
95% CI [0.98, 1.002], p = .138; body: OR = 0.985, 95% CI [0.94, 1.007], p = .176) and the
presence of delusions.
In additional post-hoc logistic regression block design models, we analyzed the
relationship between CA1 volumes and APOE ε4 allele status as a binary factor (presence or
absence of ε4 alleles) on the presence of delusions. The same models were used with age, sex,
and site included in Block 1, binary APOE ε4 allele status included in Block 2, CA1 volume and
whole hippocampal volume were in Block 3, and APOE ε4 allele × CA1 volume interaction was
Block 4.
For the left CA1, there was no significant association between CA1 volume and the
presence of delusions (OR = 0.999 [95% CI: 0.987, 1.011]; p = .886) and there was no
significant association in the interaction between the left CA1 volume × APOE ε4 allele status
and the presence of delusions (OR = 1.000 [95% CI: 0.993, 1.007]; p = .978). For the right CA1,
the addition of Block 4, the interaction between APOE presence and right CA1 volumes, reached
significance (R2 = .180; χ2 = 76.93, p = .049), however, this association did not survive
Bonferroni correction. There was a significant association between right CA1 volumes and the
presence of delusions (OR = 0.988 [95% CI: 0.977, 1.000]; p = .042), however, this association
also did not survive correction for multiple testing (α < 0.025). There was no significant
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association in the interaction between the right CA1 volume × APOE ε4 allele presence and the
presence of delusions (OR = 1.007 [ 95% CI: 0.999, 1.014]; p = .085). See Supplemental Table 1
for more details on the block design results for binary APOE ε4 allele presence.
MMSE. There were no significant differences between individuals without delusions (M =
22.37, SD = 5.28) and individuals with delusions (M = 22.80, SD = 3.88) on MMSE scores (t = 0.803, p = .212). MMSE scores were significantly correlated with left CA1 volumes (r = .130, p
= .005) and left (r = .155, p = 8.15E-4) and right (r = .108, p = .021) whole hippocampus
volumes and right CA1 volumes (r = .095, p = .041) but this last interaction did not survive
Bonferroni correction. There was a significant difference in APOE ε4 allele status (F(2) = 3.371,
p = .035) and MMSE scores but this interaction also did not survive Bonferroni correction (α <
0.025).
Linear regression block design models were used to analyze the relationship between CA1
volumes and APOE ε4 allele status on MMSE scores. For the left CA1 volume, only the addition
of Block 3 (left CA1 volume and left hippocampus) improved the predictiveness of the model
(final adjusted R2 = .018; F(6) = 2.139, p = .048) but this association did not survive multipletest correction. The addition of Block 4 (the interaction between left CA1 and APOE ε4 allele
status) did not improve the model (F(7)= 1.838, p = .079). For the right CA1 volume, only the
addition of Block 3 (right CA1 volume and right hippocampus; F(6) = 1.571, p = .154) improved
the predictiveness of the model adjusted (R2 = .009) but none of the block models reached
significance. See Table 7 for more details on the adjusted R2 of each model.
Table 7. Adjusted R2 Block Design Results for Left and Right CA1 on MMSE Scores.
Adjusted R2

F

Mean Square

p

.005

1.601

41.174

.189

Left CA1
Age, Sex, Site
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APOE ε4 allele

.005

1.432

36.848

.223

Left CA1 & whole hippocampus

.018

2.139

54.295

.048

Left CA1 × APOE ε4 allele

.015

1.836

46.712

.079

Age, Sex, Site

.005

1.601

41.174

.189

APOE ε4 allele

.005

1.432

36.848

.223

Right CA1 & whole hippocampus

.009

1.571

40.239

.154

Right CA1 × APOE ε4 allele

.008

1.430

36.668

.192

Right CA1

p value passing Bonferroni corrected α < .025. No results reached significance.

*

There were no significant associations between MMSE and either the left CA1 volume (β
= -0.105, p = .503) or the right CA1 volume (β = -0.024, p = .892). The interaction of left CA1
volume × APOE ε4 allele status (β = -0.012, p = .827) was not significantly associated with
MMSE. See Figure 7 for more details of the interaction. The interaction of the right CA1 volume
× APOE ε4 allele status was also not significantly associated (β = 0.042, p = .441) with MMSE
score. See Table 8 for more details and see Figure 8 for the spread of right CA1 volumes across
MMSE scores.
Figure 7. Interaction of APOE ε4 allele and Left CA1 volume on MMSE Scores.

Fig 7. Results showed the interaction of APOE ε4 alleles and Left CA1 volumes was not significantly
associated with the spread of MMSE scores.
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Table 8. Linear Regression Block 4 Results Examining MMSE Scores and CA1 Volumes.
Left CA1
β
t
p
-0.004
-.079
.937
Age
0.010
0.193
.847
Sex
-0.115
-2.210
.028
Site
-0.030
-0.571
.568
APOE ε4 allele
-0.105
-0.670
.503
Left CA1 (mm3)
0.238
1.498
.135
Left whole hippocampus
-0.012
-0.218
.827
APOE ε4 allele × left CA1
Right CA1
-0.031
-0.572
.567
Age
0.001
0.022
.982
Sex
-0.108
-2.080
.038
Site
-0.034
-0.637
.525
APOE ε4 allele
3
-0.024
-0.136
.892
Right CA1 (mm )
0.137
0.772
.441
Right whole hippocampus
0.042
0.771
.442
APOE ε4 allele × Right CA1
p value passing Bonferroni corrected α < .025. No results reached significance.

*

Figure 8. Interaction of APOE ε4 allele and Right CA1 volume on MMSE Scores.

Fig 8. Results showed that the interaction of APOE ε4 alleles and right CA1 volumes was not
significantly associated with the spread of MMSE scores.
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In the Pearson’s correlation models, MMSE scores were compared to the left and right
CA1 subfield volumes, head and body. MMSE was positively correlated with both the left CA1
head (r = .126, p = .007) and the left CA1 body (r = .016, p = .023) and with the right CA1 head
(r = .093, p = .046) but this last association did not survive Bonferroni correction. In linear
regression block design models, we analyzed the relationship between the left and right CA1
subfield volumes, head and body, and APOE ε4 allele status on MMSE scores. The additional
CA1 subfields did not significantly change the original models of CA1 volumes. In the left CA1
head model, the addition of Block 3 (left CA1 head volume and left hippocampus) improved the
model (adjusted R2 = .018; F(6) = 2.146, p = .048) but none of the models reached Bonferroni
correction significance. Neither the right CA1 head nor right CA1 body block designs were
significant. See Supplemental Table 2 for more details on these CA1 subfields.
Last, we analyzed the relationship between CA1 volumes and APOE ε4 allele status as a
binary factor (presence or absence of ε4 alleles) on MMSE Scores. For the left CA1 volumes,
Block 3 (left CA1 and left hippocampus) was the most predictive model (adjusted R2 = .024;
F(6) = 2.566, p = .019) and survived Bonferroni correction (α < 0.025). See Table 9 and Figure 9
for more details. For the right CA1 volumes, each block improved the predictiveness of the
model but none of the blocks reached significance.
Table 9. Linear Regression Block Design Results for CA1 Subfields on MMSE Scores and
binary APOE ε4 alleles.
Adjusted R2

F

Mean Square

p

Age, Sex, Site

.005

1.601

41.174

.189

APOE ε4 allele (binary)

.013

2.250

57.381

.063

Left CA1 & whole hippocampus

.024

2.566

64.691

.019*

Left CA1 × APOE ε4 allele (binary)

.022

2.205

55.723

.033

Left CA1
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Right CA1
Age, Sex, Site

.005

1.601

41.174

.189

APOE ε4 allele (binary)

.013

2.250

57.381

.063

Right CA1 & whole hippocampus

.016

2.029

51.600

.061

Right CA1 × APOE ε4 allele (binary)

.015

1.804

45.941

.085

p value passing Bonferroni corrected α < .025.

*

Figure 9. Significance of Presence of APOE ε4 allele and Left CA1 volume on MMSE
Scores.

Fig 9. Results showed that the Left CA1 volumes were significantly associated with MMSE scores and that
relationship was moderated by APOE ε4 allele presence.
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AIM II: CONFIRMATION OF THE RELATIONSHIP BETWEEN CA1 VOLUME,
PRESENCE OF DELUSIONS, AND APOE ε4 ALLELE STATUS THROUGH HIGHRESOLUTION T2 IMAGES
Hippocampal subfields are heterogeneous in cytoarchitecture and function (Chase et al.,
2015; Eckermann et al., 2021; Small et al., 2011). Examination of subfield-specific changes allows
for an accurate relationship of the subfield and its function or relationship to disease state.
However, subregions of the hippocampus are especially difficult to accurately measure due to their
small size and insufficient signal contrast with typical MRI acquisition. In addition, the resolution
of hippocampus subfield segmentation from ~1 mm3 MRI may be insufficient for valid
visualization of the internal structures of the hippocampus, how the hippocampus is segmented
(Wisse et al., 2021). Therefore, to build upon the findings from Aim I with more accurate
segmentation, Aim II used the preprocessed high resolution (0.4x0.4x2 mm3) T2 MRI images from
ADNI3 data and the hippocampal segmentation completed by Dr. Paul Yushkevich at the
University of Pennsylvania using the Automatic Segmentation of Hippocampal Subfields (ASHS;
https://www.nitrc.org/projects/ashs). ASHS allows for automatic segmentation of the hippocampal
subfields from the T1-weighted scan and T2-weighted images to obtain optimal segmentation
(Wisse et al., 2016, 2021). Further details on the segmentation differences have been thoroughly
described in the original paper and subsequent literature (Iglesias et al., 2016; Wisse et al., 2021).

3.1 Aim and hypothesis
We used the T2 MRI images from the ADNI3 dataset as confirmatory data to test the
specificity of the CA1 volume change. In this aim, we re-tested the hypotheses from Aim I, that
there is a moderating effect of the APOE ε4 allele on the relationships between CA1 volume and
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presence of delusions and AD cognitive status while modeling the other hippocampal subfields.
More specifically we examined if the CA1 volumetric differences were unique to its region or if
the other hippocampal subfields (CA2 and CA3) also presented with volumetric changes in
individuals with delusions. This approach allows for a more precise analysis of CA1 volume as a
biological correlate of the APOE ε4 pleiotropic effect because we compared different subfields of
the hippocampus. We utilized the extracted hippocampal subfields (CA1, CA2, and CA3) in the
ADNI3 dataset for Aim II.

3.2 Methods
3.2.1 Participants
For Aim II, we used the coronal high-resolution T2 images from participants acquired at 3T
scanners specifically focused on the medial temporal lobe (MTL) subregion. These images are
intended to quantify changes in the hippocampal subfields and parahippocampal gyrus subregions.
The ASHS volume data (version 2022-02-15) were downloaded from the ADNI website
(https://ida.loni.usc.edu/). There were a total of 1978 volume entries from 1137 individuals. The
most recent scan (determined by the scan date) was used for all subsequent analyses. Only
confirmed Alzheimer’s disease (AD) dementia diagnoses were included; there were a total of 99
individuals with AD dementia. There were 34 individuals who were included in both Aim I and
Aim II. Presence of delusions was recorded by either the Neuropsychiatric Inventory (NPI) or the
NPI-Questionnaire (NPI-Q). Of the 99 individuals, 12 endorsed delusions at the time of scan.
Quality assurance (QA > 1) removed eleven total individuals from analyses. Participant
information is listed in Table 10. The two groups (individuals with delusions and individuals
without delusions) did not significantly differ in mean age, gender distribution, mean education
attainment, or APOE ε4 allele distribution.
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Table 10. Demographic Information from ADNI3.
Delusions

No Delusions

t

χ2

p

N

11

77

__

__

__

Age (M; SD)

71.69 (9.74)

70.38 (11.34)

-0.366

__

.358

Sex (Males %)

4 (36.36%)

44 (57.14%)

__

1.68

.195

Race
(Caucasian %)

8 (72.72%)

72 (93.50%)

__

5.410

.067

MMSE

17.33 (6.63)

22.12 (4.81)

2.641

__

.005*

Education

16.89 (1.76)

15.75 (2.35)

-1.399

__

.083

3 0 ε4 allele

26 0 ε4 allele

5 1 ε4 allele

35 1 ε4 allele

__

5.076

.079

3 2 ε4 alleles

16 2 ε4 alleles

ICV (M; SD)

1,241,878.55
(78,771.145)

1,329,247.69
(143,977.960)

3.027

__

.003*

Left CA1
volume (mm3)

968.86
(247.88)

945.84 (251.51)

-0.284

__

.388

Right CA1
volume (mm3)

962.13
(197.03)

938.16 (226.52)

-0.333

__

.370

APOE ε4 alleles

AD: Alzheimer’s disease; M: mean; SD: standard deviation; MMSE: Mini-Mental State Exam; ICV: intracranial
volume. Race breakdown was as follows in delusion group: 8 Caucasian, 2 African American, 1 Asian; in non-delusion
group: 72 Caucasian, 4 African American, and 1 Asian. *p value passing Bonferroni corrected α < .025.

3.2.2 Assessments
The same assessments from Aim I were utilized for Aim II. Refer to Chapter 2 for more
information on the Neuropsychiatric Inventory-Questionnaire (NPI-Q) and Mini-Mental State
Exam (MMSE).

3.2.3 Image Processing
Volumetric measurements of subregions of the medial temporal lobe were generated by
applying ASHS software (https://sites.google.com/site/hipposubfields/) to the hippocampal T2-
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weighted MRI scans of the ADNI3 subset (Yushkevich et al., 2015). Within Freesurfer v6.0, the
segmentation tool generates an automated segmentation of the hippocampal subfields based on a
statistical atlas built on ultra-high resolution (~1 mm isotropic) ex vivo MRI data. For the purposes
of this study, cortical reconstruction and volumetric segmentation have already been performed
with FreeSurfer (Fischl, 2012) v6.0 image analysis suite on the ADNI3 dataset, resulting in
volumetric estimations of each subregion. Briefly, a multiatlas label fusion technique produces a
fully automated segmentation of the hippocampal subfields along the entire length of the
hippocampal formation. The automated process has been previously described in the literature
(Wisse et al., 2016). For the purposes of this Aim, the following subfields were extracted for
analysis: left and right CA1, left and right CA2, left and right CA3, and total ICV. Following the
outlined guidelines, only segmented images with Quality Assurance (QA) scores ≥ 2 were used.

3.2.4 Statistical Analyses
Statistical analysis was performed in SPSS 28.0.0.0 (IBM Corp. Released 2020. IBM SPSS
Statistics for Windows, Version 27.0. Armonk, NY: IBM Corp).

3.2.5 Statistical Model
To determine whether the CA1 subfield volumes were related to the presence of delusions
and if that relationship was moderated by the APOE ε4 allele, a repeated measure general linear
model (GLM) was performed with the CA1, CA2, and CA3 subfields as within-subjects factors,
The same models from Aim I were applied to the ADNI3 dataset and those results are listed in the
Supplemental Material. APOE ε4 allele status and delusion presence as between-subjects factors,
and with age, sex, and site as covariates. The conservative Bonferroni correction was employed
for multiple testing (p values had to exceed .05/ (number of hippocampus subfields*number of
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between-subjects factors) = 0.01. The relationship between MMSE scores, APOE status, and CA1
volume was examined using a repeated measures general linear model (GLM). The model included
the CA1, CA2, and CA3 hippocampal subfields as within-subjects variables. APOE ε4 allele status
and MMSE scores were included as between-subjects variables. Intracranial volume (ICV), age,
sex, and site were included as covariates.

3.3 Results
Examining mean differences using analysis of variance (ANOVA), the left and right CA1
subfield volumes were compared across the APOE ε4 allele distribution and there were no
significant difference between each allele status (left: F = 0.252, p = .778; right: F = 1.096, p =
.339). Examining mean differences using t-tests, nonsignificant differences were found between
both the left and right CA1 subfield volumes of those presenting with delusions (left: M = 968.86,
SD = 247.88; right: M = 962.13, SD = 197.03) and those presenting without delusions (left: M =
945.84, SD = 251.51; right: M = 938.16, SD = 226.52; left: p = .388; right: p = .370). However,
there was a significant difference in total ICV between individuals with delusions and individuals
without delusions (t = 3.027, p = .003).
Delusions. A repeated measures GLM showed that the left CA1 volumes were not differently
affected by either APOE ε4 allele status (F(2) = 0.458, p = .634) nor the presence of delusions
(F(1) = 1.511, p = .223) when compared to the CA2 and CA3 subfield volumes. The right CA1
volumes were also not differently affected by either APOE ε4 allele status (F(2) = 0.149, p = .862)
nor the presence of delusions (F(1) = 0.001, p = .974) when compared to the CA2 and CA3 subfield
volumes. See Table 11 and Figures 9 and 10 for more details on the interactions.
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Table 11. Repeated Measures ANOVA Results Comparing Delusions across CA Subfields.
F
MS
df
p
Partial η
squared
Left CA1
Intercept

1.724

29064.642

1

.193

.022

ICV

25.171

424294.160

1

3.00E-6*

.244

Age

0.014

231.770

1

.907

.000

Sex

0.886

14941.410

1

.349

.011

Site

0.242

4081.404

1

.624

.003

Delusions

1.511

25471.064

1

.223

.019

APOE ε4 allele

0.458

7715.824

2

.634

.014

Delusions × APOE ε4 allele

0.559

9417.608

2

.574

.014

Intercept

0.103

1564.216

1

.749

.001

ICV

16.483

249470.068

1

1.17E-4*

.176

Age

0.025

384.008

1

.874

.000

Sex

4.076

61690.011

1

.047

.050

Site

0.186

2822.329

1

.667

.002

Delusions

0.559

8467.409

1

.457

.007

APOE ε4 allele

0.455

9555.591

2

.636

.012

Delusions × APOE ε4 allele

0.450

6806.682

2

.639

.012

Right CA1

*Bonferroni corrected p < .01; df: degrees of freedom. ICV: intracranial volume (mm3); Mauchly’s test of
sphericity (p < .001) adjusted df for averages tests of significance. Sex coded: Females = 2, Males = 1.
Neither set of tests (left or right) passed significance.

DELUSIONS IN ALZHEIMERS DISEASE

45

Figure 10. Interaction of Delusions and APOE ε4 allele on Left CA1 volume (mm3).

Fig 10. Results showed there was no significant interaction between APOE alleles and left CA1 volumes
between individuals with delusions and individuals without delusions.

Figure 11. Interaction of Delusions and APOE ε4 allele on Right CA1 volume (mm3).

Fig 11. Results showed there was no significant interaction between APOE alleles and right CA1 volumes
between individuals with delusions and individuals without delusions.
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Independent samples t-tests showed a significant difference between the two groups (t =
2.641, p = .005) on MMSE scores. Individuals with delusions had an average MMSE score of
17.33 (SD = 6.63) and individuals without delusions had an average MMSE score of 22.12 (SD =
4.81). One-way ANOVA found no significant different across the APOE ε4 allele status and
MMSE scores (F(2) = 0.254, p = .776). Pearson’s correlations showed no significant relationship
between MMSE scores and left CA1 subfield volumes (r = .198, p = .105) or between MMSE
scores and right CA1 subfield volumes (r = .220, p = .074). There was also no significant
correlation between MMSE scores and education attainment (r = -.044, p = .725). MMSE scores
were significantly correlated with ICV volumes (r = .295, p = .015) and therefore, ICV was added
to the repeated measures GLMs.
MMSE. A repeated measures GLM found that left CA1 volumes were not differently affected
by either APOE ε4 allele status (F(2) = 0.790, p = .463) nor total MMSE score (F(17) = 0.697, p
= .781) when compared to the CA2 and CA3 subfield volumes. The right CA1 volumes were also
not differently affected by either APOE ε4 allele status (F(2) = 1.171, p = .324) nor by the MMSE
scores (F(17) = 0.906, p = .574) when compared to the CA2 and CA3 subfield volumes. See Table
12 and Figures 12 and 13 for more details on the interactions. APOE ε4 allele status was also
recoded as a binary factor and the repeated measures GLMs were analyzed with binary ε4 allele
presence but the results did not differ significantly.
Table 12. Repeated Measures ANOVA Results Comparing MMSE across CA Subfields.
F
MS
df
p
Partial η
squared
Left CA1
Intercept

0.842

17146.141

1

.366

.028

ICV

9.436

192136.472

1

.005*

.245
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Age

0.019

392.935

1

.890

.001

Sex

2.349

47827.210

1

.136

.075

Site

0.037

747.014

1

.849

.001

MMSE

0.697

14191.815

17

.781

.290

APOE ε4 allele

0.790

16080.748

2

.463

.052

MMSE × APOE ε4 allele

0.481

9793.391

14

.925

.188

Intercept

0.901

15865.248

1

.350

.030

ICV

2.665

46917.970

1

.113

.084

Age

0.011

195.845

1

.917

.000

Sex

2.283

40199.425

1

.142

.073

Site

0.665

11708.866

1

.421

.022

MMSE
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Figure 12. Left CA1 volume (mm3) across MMSE Scores distribution.

Fig 12. Results showed that the left CA1 volumes were not significantly associated with MMSE scores and
that relationship was not significantly moderated by APOE ε4 allele presence.

Figure 13. Right CA1 volume (mm3) across MMSE Scores distribution.

Fig 13. Results showed that the right CA1 volumes were not significantly associated with MMSE scores and
that relationship was also not significantly moderated by APOE ε4 allele presence.
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DISCUSSION
This study is one of the first to examine the specific symptom phenotype of delusions in
Alzheimer’s disease (AD) and its relationship to the hippocampal CA1 subfield and genotypic
presentations. We expected a moderation of the relationship between CA1 volumes and presence
of delusions and MMSE scores based on the APOE ε4 allele status. We acknowledge that the
APOE ε4 allele status would not cause CA1 volume atrophy as cortical atrophy is observed in all
individuals regardless of APOE ε4 allele status. However, we hypothesized that the APOE ε4 allele
would moderate the relationship between CA1 atrophy and presence of delusions (as measured by
the NPI-Q) such that the more APOE ε4 alleles an individual had, the more likely they would be
to present with delusions regardless of CA1 volume. In the combined dataset (ADNI and OASIS)
our results showed that there was no significant difference between individuals with delusions and
individuals without delusions in any of the tested demographic information (age or sex) or in the
distribution of APOE ε4 alleles, MMSE scores, or level of education.
These results indicate support for a possible neural aspect that is relating to, explaining, or
causing the presence of delusions as our results show that the delusions are not explained by
differences in cognitive impairment, diagnosis, age, or genetic presentation. From these results,
we maintain our hypothesis that the cognitive status of AD (as measured by the MMSE) and
delusions are two distinct clinical phenotypes relating to AD therefore, delusions are not an
outcome or symptom of Alzheimer’s disease and may have a unique neural component.
In Aim I, results show that individuals with delusions had significantly smaller right
hippocampal volumes and smaller right CA1 subfield volumes when compared to individuals
without delusions. Our results also found that the presence of delusions was not significantly
related to the number of APOE ε4 alleles. The logistic regression model with age, sex, site, and
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whole hippocampal volume also found no significant interaction between APOE ε4 alleles and
either the left or right CA1 volumes in individuals with delusions. More specifically, the right
CA1 subfield volume was smaller in individuals with delusions, but that association was not
related to APOE ε4 alleles nor did that association survive multiple test correction.
In Aim I, individuals with delusions did not present with significantly different MMSE
scores compared to individuals without delusions. MMSE score were significantly correlated
with the left CA1 volume and both the left and right whole hippocampal volumes. There was a
significant effect of APOE ε4 alleles on MMSE scores, which was to be expected given APOE
ε4 allele’s increased risk for AD severity (Belloy et al., 2019; Corder et al., 1993). However, in a
similar manner as delusions, the MMSE association with hippocampal volumes and APOE ε4
alleles did not survive once age, sex, and site were accounted for in the model. There was no
significant interaction between APOE ε4 alleles and CA1 volumes (right or left) with either the
presence of delusions or the MMSE scores.
In Aim II, we used high resolution T2 images from a subset of the ADNI dataset to further
expand upon the findings of Aim I. The goal of Aim II was to examine possible CA1 volumetric
differences in the individuals with delusions and determine if the differences in the CA1 were
unique to that subfield by comparing it to the other hippocampal subfields (CA2 and CA3). The
high resolution of T2 MRI images lends itself to a more accurate segmentation of the
hippocampus along subfield lines, allowing for a more precise analysis of CA1 volume as a
biological correlate of the APOE ε4 pleiotropic effect. The improvement in segmentation
accuracy is observable by the increase in average CA1 volumes when comparing across Aim I
and Aim II.
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There was a significant difference in the total intracranial volume between individuals with
delusions and individuals without delusions. However, we did not observe any significant
differences in the CA subfields of the hippocampus in relation to the APOE ε4 alleles on either
the presence of delusions or the MMSE scores. The number of APOE ε4 alleles did appear to
influence the relationship between CA1 volumes and MMSE as observed in Figures 11 and 12,
with the positive relationship between both the left and right CA1 volumes and MMSE
decreasing with increased number of APOE ε4 alleles. However, neither of those associations
reached significance. One noted limitation that will discussed further is the resulting small
sample size of the ADNI3 dataset for Aim II.
Overall, these results do not support the original hypothesis that there is a moderating
relationship of the APOE ε4 allele between the CA1 subfield volumes and delusions. In addition
to the limitations of the study design, we hypothesize two explanations for the lack of significant
reductions within the CA1 subfields observed in individuals with delusions. As noted in Aim II,
the hippocampal segmentation resulting from ~1mm3 T1 images may not be a valid measure of
the true volumes of the individual hippocampal subfields (Wisse et al., 2021). Our results show
support for this claim as the average CA1 volume increased substantially from the T1 images in
Aim I to the T2 images in Aim II. Furthermore, in comparing the small subset of individuals who
were included in both sets of analyses, there were noted increases in CA1 volumes even within
the same person. Therefore, we conclude that our results from Aim I did not show a moderating
relationship of the APOE ε4 allele on CA1 volumes in individuals with delusions partially
because of the small subfield segmentations. However, there was still no significant association
identified in Aim II. Therefore, lack of significant findings cannot be solely explained by the
hippocampal segmentation.
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Our second explanation relates to the sample’s rate of APOE ε4 allele presentations. In this
study, 73.53% of individuals with delusions had at least one APOE ε4 allele, whereas 61.42% of
individuals without delusions had at least one APOE ε4 allele compared to 13.7% of individuals
in the general population. Although the APOE ε4 allele is related to an increased risk for
Alzheimer’s disease and especially late-onset Alzheimer’s disease (Belloy et al., 2019; Corder et
al., 1993), our results show that possession of an APOE ε4 allele was not related to an increased
risk for delusions. In both set of results, there was no significant association between APOE ε4
allele possession and the presence of delusions. As mentioned above, a trend, but non-significant,
of the APOE ε4 allele was also observed in the relationship between MMSE scores and CA1
volumes from Aim II. In other words, possession of the APOE ε4 allele resulted in worse MMSE
scores even with large CA1 volumes when compared to individuals without APOE ε4 alleles.
Given these findings, we argue that the APOE ε4 allele may not be the cause of effect in the
relationship between delusions and the CA1. Although the previous literature points to a potential
relationship between APOE ε4 alleles and delusions, it is possible that the APOE ε4 allele is related
to more severe presentations as well as late-onset AD and delusions tend to present in later stages
of the disease. Previous GWAS studies have reported a small (but significant) association between
the APOE ε4 allele and psychosis in large studies (N > 12,000) but there are also some inconsistent
findings in smaller sample sizes (Creese et al., 2019; DeMichele-Sweet et al., 2018, 2021; Shah et
al., 2017). Therefore, the APOE ε4 allele and delusions may be observed in the same AD
presentations but are not directly related. To examine this limitation, we removed APOE ε4 alleles
and its interaction with the CA1 subfields from the models in Aim I, but there were no notable
differences to the results. We conclude that we did not find support for possession of the APOE
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ε4 allele indirectly influencing the presentation of delusions because of the small sample size and
the weighted percentage of APOE ε4 allele possession already in this AD sample.
Examination of the entire symptom profile of individuals presenting with delusions within
AD may inform the pathophysiology better than examination of the symptom as a single entity.
Previous studies have identified that individuals with depression and AD had an increased rate of
delusions compared to individuals without depression (Bassiony et al., 2002). Delusions in AD
were also significantly associated with agitation and physical aggression, in addition to depression
(Mizrahi et al., 2006). There are also high rates of delusions and hallucinations presenting together
in AD and other dementias (Dave et al., 2020; Ffytche et al., 2017; Fischer & Sweet, 2016; Murray
et al., 2014; Sakai et al., 2019). These symptoms may simply be co-occurring within the
complexities if Alzheimer’s disease, may be secondary to the cognitive deficits and other
functional difficulties that arise from Alzheimer’s disease, or may relate to the same
pathophysiology and therefore, should be studied as an whole symptom presentation to fully
understand the genetic and neural underpinnings of delusions in AD.
The lack of significant structural findings in this study may indicate that a more accurate
description of this relationship is the connectivity of the CA1 subfield within the cortex. As
previously mentioned, the CA1 subfield has been implicated in novelty detection, information
input comparison, autobiographical memory, and autonoetic consciousness. Previous literature
examining the CA1 have found associations with the CA1 and psychosis that were not only
volumetric. Pyramidal cell death in the CA1 was originally hypothesized as a primary cause of
paranoid delusions (Krieckhaus et al., 1992). Lower neuron counts in the CA1 were related to
misidentification delusions (Förstl et al., 1994) and focal brain lesions were identified in the CA1
regions of individuals who presented with Capgras delusion (Feinberg & Keenan, 2005). In
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addition, functional connectivity found CA1 alterations were related to overall positive symptoms
in schizophrenia and other psychiatric disorders (Schobel et al., 2009). Therefore, we conclude
that a potential CA1 subfield and delusion relationship should be further examined in connectivity
studies.
Another approach to examining the CA1 and delusion relationship may be longitudinal
studies. Using the ADNI dataset, researchers found greater rates of volumetric atrophy in the left
hippocampus and bilaterally in the parahippocampal gyri in individuals with delusions compared
to individuals who did not develop delusions (Manca et al., 2022). Atrophy was observed in other
regions along the dopaminergic pathway, indicating support for the CA1 being a small part of a
larger network relating to delusions (Manca et al., 2022). Examination of the findings showed
insignificant differences across groups in the final time point (as we did in this current study) but
the change over time between the two groups was significant. Therefore, our cross-sectional
approach may have limited the potential for observing differences in the CA1 volumes of
individuals with and without delusions.
Although our findings do not directly support a relationship between CA1 subfields, APOE
ε4 allele and delusions, we did find that individuals with delusions present with significantly
smaller right CA1 volumes compared to individuals without delusions. Therefore, there is still
support for the CA1 playing a role in the presence of delusions. The CA1 subfield relates and has
connections to the sensorimotor cortex, amygdala, orbitofrontal cortex, medial and lateral temporal
poles, and the nucleus accumbens (Ezama et al., 2021). These regions are responsible for
processing of discriminatory sensory information, which may indicate that a dysfunction in these
regions could relate to a lack of discrimination in incoming sensory information and that may
explain the development and maintenance of delusions. Furthermore, reduced activation was
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observed in the spatiotemporal/visual attention region in individuals with schizophrenia and
delusions in the face of weak evidence when compared to individuals without delusions. These
results imply that individuals with delusions do not scrutinize weak evidence to the same extent as
individuals without delusions (Fouladirad et al., 2022). However, the directionality of the
connectivity in delusions is still unclear. In AD individuals with delusions, weaker connectivity
was observed in the default mode network (DMN) and the superior temporal gyrus, left interior
orbitofrontal and right medial orbitofrontal (Qian, Fischer, et al., 2019). On the other hand,
increased connectivity between the hippocampus and the amygdala was observed in individuals
experiencing paranoia, a common theme of delusion presentation (Walther et al., 2022). These
results indicate that delusions may be a product of dysfunction of connected networks in the brain,
specifically the hippocampus, and not solely a loss of function associated with a loss of gray matter
volume. The question remains as to what causes the dysfunction in these networks if it is not
specifically a greater loss of volume.

4.1 Limitations
There are a few limitations of this study. To begin, both Aims were severely limited in
sample sizes. Given the quality of the T1 MRI and T2 MRI images as well as the number of
participants with completed assessments, the sample sizes were smaller than originally proposed.
Power analyses were completed prior to study to confirm that the sample sizes would yield
sufficient effect sizes. With moderate effect size (0.20 for F test), α level at 0.025, the minimal
total sample size to achieve power over 90% (assuming equal sample size in each group) is 108
(54 for each group) (Faul et al., 2007). In Aim I, our delusion sample size (N = 73) was slightly
above this power requirement. In Aim II, our delusion sample size was severely under this power
requirement (N = 11). Although we tried to overcome the limitations of a small sample by
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examining one predefined region of interest (the CA1 subfield), a moderate effect size may have
been overly optimistic for either Aim. If we set effect size to be small, effect size = 0.2, α level at
0.025, and power = 0.90, the minimal total sample size would be 450 (225 for each group), in
which case all our analyses are underpowered.
Second, the use of the MMSE may not be an accurate representation of general cognitive
status. The MMSE is a useful symptom tool for individuals with normal cognitive functioning or
mild and moderate cognitive decline. In addition to the previously mentioned limitations of the
MMSE observed across education levels, gender, and race/ethnicity, it has also been noted that
high scores can be achieved on the MMSE even if the individuals have significant cognitive
deficits and this is especially noted in individuals with higher levels of baseline education (e.g.,
completed college degrees and above). We examined education levels and there was a significant
correlation between MMSE and education (see Supplemental Material) but there were no noted
differences in education between individuals with delusions and individuals without delusions or
correlations between education and site, age, or APOE ε4 allele distribution.
Third, the examination of delusions within the context of AD can be challenging to
accurately assess. Furthermore, the binary categorization of this complex symptom has
limitations. Without examining the nature and type of the delusion, we were assuming that all
delusion presentations would have the same association with the APOE ε4 allele and CA1
subfield volume. However, there are multiple delusion types that may support the notion of
different networks relating to different presentations. Delusion type falls broadly into twelve
different categories with some discrepancies: persecutory, jealousy, grandiosity, religious,
delusion of reference, erotomania, guilt, somatic, and passive delusions such as, thought
withdrawal, thought insertion, thought broadcasting, and the delusion of being controlled. There
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are additional categories of delusions that are more specific, such as Capgras delusion (believing
family members are replaced by an identical imposter) and Othello’s syndrome (delusional
jealousy about family members) that have been observed across disorders (Moro et al., 2013).
Most notably, individuals with Alzheimer’s disease tend to report delusions of
misidentification and persecutory delusions. Different types of delusions may indicate different
underlying psychopathological constructs (e.g., deficits in self-monitoring versus deficits in
source monitoring). Future studies should examine the full spectrum of the delusion presentation
to determine if any one presentation relates more to volumetric changes in the hippocampus and
specifically the CA1 subfield.

4.3 Conclusions
In this study, we examined the relationship between APOE ε4 allele status, CA1 subfield
volumes, and the presence of delusions in a combined Alzheimer’s disease dataset. We also
sought to examine the specificity of relationship between delusions and the CA1 subfield as it
related to the other hippocampal subfields. We did not find a significant relationship between the
CA1 subfields, APOE ε4 alleles, and the presence of delusions. Individuals with delusions had
significantly smaller right CA1 volumes and APOE ε4 allele did moderate a relationship between
left CA1 volumes and MMSE scores but no other findings were significant. We caution that
these findings do not completely dissuade a relationship between the CA1 subfield and delusions
as no other notable differences were found. Further comparisons were unable to find any
significant group differences in any participant demographic information. Therefore, we
conclude that there is still a possibility of an association between the CA1 subfield and delusions,
but future research is needed to examine functional connectivity aspects of the CA1 and more
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broadly, the hippocampus, and how this region may be relating to the presence of delusions in
AD.
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Supplemental Material
Supplemental Table 1. Binary APOE ε4: Cox and Snell R2 and Total Model χ2 Change.
Cox and Snell
R2

Block χ2

p

Total
model χ2

p

Age, Sex, Site

.165

69.59

.075

69.59

.075

APOE ε4 allele (binary)

.169

2.17

.141

71.75

.064

.170

0.161

.923

71.91

.088

.170

.001

.978

71.91

.104

Age, Sex, Site

.165

69.59

.075

69.59

.075

APOE ε4 allele (binary)
Right CA1 & Whole
hippocampus
Right CA1 × APOE ε4 allele
(binary)

.169

2.17

.141

71.75

.064

.173

1.95

.377

73.70

.068

.180

3.22

.073

76.93

.049

Left CA1

Left CA1 & Whole
hippocampus
Left CA1 × APOE ε4 allele
(binary)
Right CA1

In addition to the analyses described in the main manuscript, we also examined
educational attainment across multiple variables. There was no significant difference across
APOE alleles and educational attainment (F(2)=0.433, p = .649). Although individuals with
delusions had less average education scores, there was no significant difference in education
between individuals with delusions (M = 14.97, SD = 3.023) and individuals without delusions
(M = 15.19, SD= 2.93; t = 0.571, p = .284). There was a significant correlation between MMSE
and education (r = .096, p = .043).
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Supplemental Table 2. Linear Regression Block Design Results for Left and Right CA1
Subfields on MMSE Scores.
Adjusted R2

F

Mean Square

p

.005

1.601

41.174

.189

.005

1.432

36.848

.223

.018

2.146

54.453

.048

.015

1.837

46.738

.079

Age, Sex, Site

.005

1.601

41.174

.189

APOE ε4 allele

.005

1.432

36.848

.223

.017

2.062

52.395

.057

.015

1.796

45.739

.087

.005
.005

1.601
1.432

41.174
36.848

.189
.223

.009

1.575

40.343

.153

.008

1.448

37.103

.185

.005
.005

1.601
1.432

41.174
36.848

.189
.223

.009

1.572

40.258

.154

.007

1.358

34.854

.222

Left CA1 head
Age, Sex, Site
APOE ε4 allele
Left CA1 head & whole
hippocampus
Left CA1 head × APOE ε4 allele
Left CA1 body

Left CA1 body & whole
hippocampus
Left CA1 body × APOE ε4 allele
Right CA1 head
Age, Sex, Site
APOE ε4 allele
Right CA1 head & whole
hippocampus
Right CA1 head × APOE ε4 allele
Right CA1 body
Age, Sex, Site
APOE ε4 allele
Right CA1 body & whole
hippocampus
Right CA1 body × APOE ε4 allele

For Aim II, the ADNI3 T2 images were used in the same models as Aim I to compare if
the accuracy from the increased resolution would show an effect. See Supplemental Tables 3 and
4 for more details.
Supplemental Table 3. Block Design Logistic Regression with ADNI3 T2 Images.
Cox and
Block χ2
p
Total model
2
Snell R
χ2

p

Left CA1
Age, Sex, Site

.293

30.502

.861

30.502

.861
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APOE ε4 allele

.316

2.955

.086

33.457

.793

Left CA1 & ICV

.341

3.256

.196

36.713

.739

Left CA1 × APOE ε4 allele

.342

0.070

.791

36.783

.771

Age, Sex, Site
APOE ε4 allele

.293
.316

30.502
2.955

.861
.086

30.502
33.457

.861
.793

Right CA1 & ICV

.335

2.475

.290

35.932

.769

Right CA1 × APOE ε4 allele

.336

.153

.696

36.085

.796

Right CA1

*Bonferroni corrected p < .05. No results passed significance.
Supplemental Table 4. Block Design Linear Regression with ADNI3 T2 Images.
Adjusted R2
F
Mean Square

p

Left CA1
Age, Sex, Site

.047

2.082

42.170

.111

APOE ε4 allele

.032

1.543

31.736

.201

Left CA1 & ICV

.050

1.580

31.890

.169

Left CA1 × APOE ε4 allele

.049

1.490

30.091

.189

Age, Sex, Site

.047

2.082

42.170

.111

APOE ε4 allele

.032

1.543

31.736

.201

Right CA1 & ICV

.072

1.848

36.456

.105

Right CA1 × APOE ε4 allele

.070

1.710

33.790

.124

Right CA1

*Bonferroni corrected p < .05. No results passed significance.

